Gyon Technologies Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-21,796
Closed -$2.42M 250
2022
Q4
$2.42M Buy
21,796
+468
+2% +$47.8K 0.91% 24
2022
Q3
$1.84M Buy
21,328
+3,044
+17% +$272K 0.57% 49
2022
Q2
$1.67M Buy
+18,284
New +$1.62M 0.47% 68
2022
Q1
Sell
-23,286
Closed -$1.78M 456
2021
Q4
$1.78M Sell
23,286
-3,697
-14% -$294K 0.33% 81
2021
Q3
$2.03M Sell
26,983
-2,237
-8% -$170K 0.55% 57
2021
Q2
$2.27M Buy
29,220
+7,730
+36% +$575K 0.74% 25
2021
Q1
$1.58M Sell
21,490
-10,755
-33% -$793K 0.69% 26
2020
Q4
$2.52M Buy
32,245
+10,951
+51% +$838K 0.87% 22
2020
Q3
$1.69M Buy
21,294
+5,806
+37% +$455K 1.32% 3
2020
Q2
$1.14M Buy
15,488
+5,130
+50% +$386K 2.77% 9
2020
Q1
$761K Sell
10,358
-18,570
-64% -$1.46M 1.46% 28
2019
Q4
$2.51M Buy
+28,928
New +$2.38M 1.66% 19

Other funds holding MRK

Gyon Technologies Capital Management's MRK Position: Q1 2023 in Review

Gyon Technologies Capital Management sold out of Merck (MRK) in Q1 2023, closing a stake of 21,796 shares — an estimated $2.42M sold.

Gyon Technologies Capital Management first reported a position in MRK in Q4 2019 and held it in 12 quarters. The position peaked at $2.52M in Q4 2020. 3,180 funds tracked by Wall St. Rank hold MRK as of Q1 2023.

  • Gyon Technologies Capital Management reported no remaining Merck position as of Q1 2023 after selling out during the quarter.
  • Gyon Technologies Capital Management sold 21,796 Merck shares in Q1 2023, an estimated $2.42M.
  • Gyon Technologies Capital Management first reported a position in Merck in Q4 2019 and held it in 12 quarters.
  • Gyon Technologies Capital Management's Merck position peaked at $2.52M in Q4 2020.
  • 3,180 funds tracked by Wall St. Rank held Merck as of Q1 2023.

Based on Gyon Technologies Capital Management's 13F filing for Q1 2023.